June Y. Hou

National trends in opioid-related hospitalizations among adult cancer patients: 2000-2022.

Yongmei Huang, Xiao Xu, Pia M. Mauro, June Y. Hou et autres

11147 Background: Opioid use disorder is increasingly prevalent among cancer patients. Since mid-2010s, heightened attention to the opioid crisis has led to restrictive opioid prescribing policies; however, national trends in opioid-related hospitalizations (ORH) among cancer patients following these policies remain underreported. This …

us (code pays fourni par la source)

Applying decision curve analysis to evaluate a patient-centered opioid prescribing strategy among patients with laparoscopic cholecystectomy in the US

Y. Huang, Jacobson Js, Guohua Li, Pia M. Mauro et autres

us (code pays fourni par la source)

Medication for Opioid Use Disorder and Perioperative Outcomes for Benign Hysterectomy

Yongmei Huang, Ang Li, June Y. Hou, Pia M. Mauro et autres

OBJECTIVE: To evaluate the association between medication for opioid use disorder (MOUD) and surgical complications and health care utilization among patients with opioid use disorder (OUD) undergoing hysterectomy. METHODS: Using MarketScan Research Databases (2016-2021), we identified patients with OUD who underwent hysterectomy …

us (code pays fourni par la source)

Development of prediction models for perioperative opioid needs in laparoscopic cholecystectomy patients: A machine-learning approach

Yongmei Huang, Guohua Li, Silvia S. Martins, Pia M. Mauro et autres

Background: Changes in opioid prescribing practices have evolved, including perioperative settings. However, computerized clinical decision support systems to guide opioid prescribing remain limited. This study aimed to develop and validate prediction models for perioperative opioid needs among patients undergoing laparoscopic cholecystectomy (LC) …

us (code pays fourni par la source)

Trends, predictors, and safety of ovarian preservation in premenopausal women with high-grade endometrioid and non-endometrioid endometrial cancers

Jaida E. Morgan, Ling Chen, Xiao Xu, Shayan Dioun et autres

us (code pays fourni par la source)

Utilization and outcomes of fertility-sparing ovarian cystectomy for stage I malignant ovarian germ cell tumors

Delanie Ludmir, Yongmei Huang, Xiao Xu, Shayan Dioun et autres

us (code pays fourni par la source)

Table S3 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti et autres

Detailed summary of drugs prioritized for testing in PDX models, based on rank of OncoTarget and OncoTreat predictions by –log10(Bonferroni p).

Table S5 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti et autres

Comprehensive list of clinically relevant drugs screened in cell lines (not all were available at time of study). The list is divided into three sections, including one with FDA approved antineoplastics, one with experimental antineoplastics in clinical trials, and one with non-antineoplastics …

Key Resources Table from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti et autres

Key Resources Table

Table S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti et autres

Detailed summary of therapeutic response at end-of-study time point, organized by study group—OncoTreat, OncoTarget, or Negative control—and then stratified by each individual drug arm. The study was underpowered for statistical analyses of therapeutic response in individual drug arms.

Table S2 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti et autres

Prioritized drugs, prediction basis, and dosing schedule for PDX therapeutic study.

Table S8 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti et autres

List of available interactomes (gene regulatory networks) that have been generated from RNASeq datasets of patient tumor samples using the ARACNe algorithm.